|
|
||||||||
The Johns Hopkins Medical Institutions, Baltimore, Maryland
Correspondence: For reprints contact: Min-Fu Tsan, 615 North Wolfe St., Baltimore, MD 21205.
ABSTRACT
Gallium-67 was demonstrated to be taken up in significant amounts by a number of common micro-organisms. The mechanism of gallium-67 uptake was studied in S. aureus. It is found to involve two separate processes. One is insensitive to temperature or metabolic inhibitors, and is not inhibited by a high concentration of nonradioactive gallium. This process probably operates through nonspecific binding of Ga-67 to components of S. aureus. The second process is not inhibited by metabolic inhibitors either, but it is temperature-sensitive and is inhibited by high concentrations of stable gallium. This component of the Ga-67 uptake is most likely due to a carrier-mediated transport system (facilitated transfer).
This article has been cited by other articles:
![]() |
O. Olakanmi, B. E. Britigan, and L. S. Schlesinger Gallium Disrupts Iron Metabolism of Mycobacteria Residing within Human Macrophages Infect. Immun., October 1, 2000; 68(10): 5619 - 5627. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Bernstein Mechanisms of Therapeutic Activity for Gallium Pharmacol. Rev., December 1, 1998; 50(4): 665 - 682. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |